BioCentury | Jun 28, 2019
Product Development

Why tissue-agnostic drug development needs NGS to go mainstream

...Neuregulin 1 NTRK - Neurotrophic tyrosine kinase receptor RET - Ret-proto-oncogene Erin McCallister, Senior Editor BLU-667 entrectinib (RG6268, rxdx-101) Gilotrif, Giotrif, afatinib (bibw 2992, tomtovok, Tovok) Vitrakvi...
BioCentury | Oct 10, 2018
Politics & Policy

China adds insurance coverage for 17 cancer therapies

...ruxolitinib from Incyte Corp. (NASDAQ:INCY) and Novartis AG (NYSE:NVS; SIX:NOVN). Sandi Wong anlotinib (AL3818), Focus V Erbitux, cetuximab (IMC-C225) Gilotrif, Giotrif, afatinib (bibw 2992, tomtovok, Tovok) Imbruvica...
Items per page:
1 - 2 of 2